首页 > 最新文献

Current radiopharmaceuticals最新文献

英文 中文
Astatine-211 Radiopharmaceuticals; Status, Trends, and the Future. Astatine-211放射性药物;现状、趋势和未来。
IF 2.3 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.2174/0118744710262325231025075638
Mobina Rabiei, Mahboobeh Asadi, Hassan Yousefnia

The low range of alpha particles provides an opportunity to better target cancer cells theoretically leading to the introduction of interesting alpha emitter radiopharmaceuticals including 225Ac, 212Pb, etc. The combination of high energy and short range of alpha emitters differentiates targeted radiotherapy from other methods and reduces unwanted cytotoxicity of the cells around the tumoral tissue. Among interesting alpha emitters candidates for targeted therapy, 211At, one of the radioisotopes with the best optimal decay properties, shows great promise for targeted radiotherapy in some animal prostate cancer xenograft studies and bone micro tumors with significant effects compared to other beta and alpha emitters and also demonstrates interesting properties for clinical applications. However, production and application of this alpha emitter in the development of actinium-based radiopharmaceuticals is hampered by many obstacles. This mini-review demonstrates 211At production methods, chemical separation, radiolabeling procedures, 211At-radiopharmaceuticals and their clinical trials, transport, logistics, and costs and future trends in the field for ultimate clinical applications. This review showed that there are limited clinical trials on 211Ac-based radiopharmaceuticals, which is due to the low accessibility of this radioisotope and other limitations. However, the development programs of major industries indicate the development of 211Ac-based radiopharmaceuticals in the future.

α粒子的低范围提供了更好地靶向癌症细胞的机会,理论上导致引入感兴趣的α发射器放射性药物,包括225Ac、212Pb等。高能和短距离α发射器的组合将靶向放射治疗与其他方法区分开来,并减少了肿瘤组织周围细胞的不必要的细胞毒性。在靶向治疗的感兴趣的α发射器候选物中,211At是具有最佳衰变特性的放射性同位素之一,在一些动物前列腺癌症异种移植物研究和骨微肿瘤中显示出靶向放射治疗的巨大前景,与其他β和α发射器相比具有显著效果,并且还显示出临床应用的感兴趣特性。然而,这种α发射体的生产和应用在基于锕的放射性药物的开发中受到许多障碍的阻碍。这篇小型综述展示了211At的生产方法、化学分离、放射性标记程序、211At放射性药物及其临床试验、运输、物流和成本以及最终临床应用领域的未来趋势。这篇综述表明,基于211Ac的放射性药物的临床试验有限,这是由于这种放射性同位素的可及性低和其他限制。然而,主要行业的发展计划表明,基于211Ac的放射性药物在未来的发展。
{"title":"Astatine-211 Radiopharmaceuticals; Status, Trends, and the Future.","authors":"Mobina Rabiei, Mahboobeh Asadi, Hassan Yousefnia","doi":"10.2174/0118744710262325231025075638","DOIUrl":"10.2174/0118744710262325231025075638","url":null,"abstract":"<p><p>The low range of alpha particles provides an opportunity to better target cancer cells theoretically leading to the introduction of interesting alpha emitter radiopharmaceuticals including <sup>225</sup>Ac, <sup>212</sup>Pb, etc. The combination of high energy and short range of alpha emitters differentiates targeted radiotherapy from other methods and reduces unwanted cytotoxicity of the cells around the tumoral tissue. Among interesting alpha emitters candidates for targeted therapy, <sup>211</sup>At, one of the radioisotopes with the best optimal decay properties, shows great promise for targeted radiotherapy in some animal prostate cancer xenograft studies and bone micro tumors with significant effects compared to other beta and alpha emitters and also demonstrates interesting properties for clinical applications. However, production and application of this alpha emitter in the development of actinium-based radiopharmaceuticals is hampered by many obstacles. This mini-review demonstrates <sup>211</sup>At production methods, chemical separation, radiolabeling procedures, <sup>211</sup>At-radiopharmaceuticals and their clinical trials, transport, logistics, and costs and future trends in the field for ultimate clinical applications. This review showed that there are limited clinical trials on <sup>211</sup>Ac-based radiopharmaceuticals, which is due to the low accessibility of this radioisotope and other limitations. However, the development programs of major industries indicate the development of <sup>211</sup>Ac-based radiopharmaceuticals in the future.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71479152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intranasal Radioiodinated Ferulic Acid Polymeric Micelles as the First Nuclear Medicine Imaging Probe for ETRA Brain Receptor. 鼻内放射性碘化阿魏酸聚合胶束作为 ETRA 脑受体的首个核医学成像探针
IF 1.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-01 DOI: 10.2174/0118744710269885231113070356
Hend Fayez, Adli Selim, Rehab Shamma, Hassan Rashed

Introduction: The aim of this work was to prepare a selective nuclear medicine imaging probe for the Endothelin 1 receptor A in the brain.

Material and methods: Ferulic acid (an ETRA antagonist) was radiolabeled using 131I by direct electrophilic substitution method. The radiolabeled ferulic acid was formulated as polymeric micelles to allow intranasal brain delivery. Biodistribution was studied in Swiss albino mice by comparing brain uptake of 131I-ferulic acid after IN administration of 131I-ferulic acid polymeric micelles, IN administration of 131I-ferulic acid solution and IV administration of 131I-ferulic acid solution.

Results: Successful radiolabeling was achieved with an RCY of 98 % using 200 μg of ferulic acid and 60 μg of CAT as oxidizing agents at pH 6, room temperature and 30 min reaction time. 131I-ferulic acid polymeric micelles were successfully formulated with the particle size of 21.63 nm and polydispersity index of 0.168. Radioactivity uptake in the brain and brain/blood uptake ratio for I.N 131I-ferulic acid polymeric micelles were greater than the two other routes at all periods.

Conclusion: Our results provide 131I-ferulic acid polymeric micelles as a hopeful nuclear medicine tracer for ETRA brain receptor.

简介:这项工作的目的是制备脑内皮素 1 受体 A 的选择性核医学成像探针:这项工作的目的是制备一种针对大脑内皮素 1 受体 A 的选择性核医学成像探针:采用直接亲电取代法,用 131I 对阿魏酸(一种 ETRA 拮抗剂)进行放射性标记。将放射性标记的阿魏酸配制成聚合物胶束,以便经鼻脑内给药。通过比较131I-阿魏酸聚合胶束IN给药、131I-阿魏酸溶液IN给药和131I-阿魏酸溶液静脉给药后131I-阿魏酸的脑摄取量,对瑞士白化小鼠的生物分布进行了研究:使用 200 μg 阿魏酸和 60 μg CAT 作为氧化剂,在 pH 值为 6、室温和 30 分钟反应时间下,成功实现了放射性标记,RCY 为 98%。131I 阿魏酸聚合物胶束的粒径为 21.63 nm,多分散指数为 0.168。在各个时期,I.N 131I-阿魏酸聚合物胶束在大脑中的放射性吸收率和大脑/血液吸收率均高于其他两种途径:我们的研究结果表明,131I-阿魏酸聚合胶束有望成为ETRA脑受体的核医学示踪剂。
{"title":"Intranasal Radioiodinated Ferulic Acid Polymeric Micelles as the First Nuclear Medicine Imaging Probe for ETRA Brain Receptor.","authors":"Hend Fayez, Adli Selim, Rehab Shamma, Hassan Rashed","doi":"10.2174/0118744710269885231113070356","DOIUrl":"10.2174/0118744710269885231113070356","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this work was to prepare a selective nuclear medicine imaging probe for the Endothelin 1 receptor A in the brain.</p><p><strong>Material and methods: </strong>Ferulic acid (an ETRA antagonist) was radiolabeled using <sup>131</sup>I by direct electrophilic substitution method. The radiolabeled ferulic acid was formulated as polymeric micelles to allow intranasal brain delivery. Biodistribution was studied in Swiss albino mice by comparing brain uptake of <sup>131</sup>I-ferulic acid after IN administration of <sup>131</sup>I-ferulic acid polymeric micelles, IN administration of <sup>131</sup>I-ferulic acid solution and IV administration of <sup>131</sup>I-ferulic acid solution.</p><p><strong>Results: </strong>Successful radiolabeling was achieved with an RCY of 98 % using 200 μg of ferulic acid and 60 μg of CAT as oxidizing agents at pH 6, room temperature and 30 min reaction time. <sup>131</sup>I-ferulic acid polymeric micelles were successfully formulated with the particle size of 21.63 nm and polydispersity index of 0.168. Radioactivity uptake in the brain and brain/blood uptake ratio for I.N <sup>131</sup>I-ferulic acid polymeric micelles were greater than the two other routes at all periods.</p><p><strong>Conclusion: </strong>Our results provide <sup>131</sup>I-ferulic acid polymeric micelles as a hopeful nuclear medicine tracer for ETRA brain receptor.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139424420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An In-depth Analysis of the Adverse Effects of Ionizing Radiation Exposure on Cardiac Catheterization Staffs. 深入分析电离辐射暴露对心导管工作人员的不良影响。
IF 1.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-01 DOI: 10.2174/0118744710283181231229112417
Maryam Alvandi, Roozbeh Narimani Javid, Zahra Shaghaghi, Soghra Farzipour, Sahar Nosrati

Diagnostic and interventional angiograms are instrumental in the multidisciplinary approach to CAD management, enabling accurate diagnosis and effective targeted treatments that significantly enhance patient care and cardiovascular outcomes. However, cath lab staff, including interventional cardiologists, is consistently exposed to ionizing radiation, which poses inherent health risks. Radiation exposure in the cath lab primarily results from the use of fluoroscopy and cineangiography during diagnostic and interventional procedures. Understanding these risks and implementing effective radiation protection measurements are imperative to ensure the well-being of healthcare professionals while delivering high-quality cardiac care. Prolonged and repeated exposure can lead to both deterministic and stochastic effects. Deterministic effects, such as skin erythema and tissue damage, are more likely to occur at high radiation doses. Interventional cardiologists and staff may experience these effects when safety measures are not rigorously followed. In fact, while ionizing radiation is essential in the practice of radiation cardiology ward, cath lab staff faces inherent risks from radiation exposure. Stochastic effects, on the other hand, are characterized by a probabilistic relationship between radiation exposure and the likelihood of harm. These effects include the increased risk of cancer, particularly for those with long-term exposure. Interventional cardiologists, due to their frequent presence in the cath lab, face a higher lifetime cumulative radiation dose, potentially elevating their cancer risk. Protective measures, including the use of lead aprons, thyroid shields, and radiation monitoring devices, play a crucial role in reducing radiation exposure for cath lab personnel. Adherence to strict dose optimization protocols, such as minimizing fluoroscopy time and maximizing distance from the radiation source, is also essential in mitigating these risks. Ongoing research and advancements in radiation safety technology are essential in further for minimizing the adverse effects of ionizing radiation in the cath lab.

诊断性和介入性血管造影在多学科治疗冠状动脉粥样硬化症的过程中发挥着重要作用,它可以实现准确诊断和有效的针对性治疗,从而显著提高患者护理水平和心血管治疗效果。然而,包括介入心脏病专家在内的阴道实验室工作人员会持续暴露于电离辐射中,这必然会对健康造成危害。阴道实验室的辐射主要来自诊断和介入手术过程中使用的透视和放射血管造影。了解这些风险并实施有效的辐射防护措施对于确保医护人员的健康和提供高质量的心脏护理至关重要。长期和重复照射可导致确定性和随机性效应。皮肤红斑和组织损伤等确定性效应更有可能发生在高辐射剂量下。如果不严格遵守安全措施,介入心脏病专家和工作人员可能会受到这些影响。事实上,虽然电离辐射是放射心脏病学实践中必不可少的,但阴道实验室工作人员也面临着辐射照射的固有风险。另一方面,随机效应的特点是辐照与伤害可能性之间的概率关系。这些效应包括癌症风险的增加,尤其是对长期暴露于辐射的人而言。介入心脏病学家由于经常在阴道实验室工作,一生中面临的累积辐射剂量较高,可能会增加他们患癌症的风险。防护措施,包括使用铅围裙、甲状腺防护罩和辐射监测设备,在减少阴道实验室人员的辐射暴露方面起着至关重要的作用。遵守严格的剂量优化协议,如尽量缩短透视时间和尽量拉大与辐射源的距离,对于降低这些风险也至关重要。持续的研究和辐射安全技术的进步对于进一步减少阴道实验室电离辐射的不良影响至关重要。
{"title":"An In-depth Analysis of the Adverse Effects of Ionizing Radiation Exposure on Cardiac Catheterization Staffs.","authors":"Maryam Alvandi, Roozbeh Narimani Javid, Zahra Shaghaghi, Soghra Farzipour, Sahar Nosrati","doi":"10.2174/0118744710283181231229112417","DOIUrl":"10.2174/0118744710283181231229112417","url":null,"abstract":"<p><p>Diagnostic and interventional angiograms are instrumental in the multidisciplinary approach to CAD management, enabling accurate diagnosis and effective targeted treatments that significantly enhance patient care and cardiovascular outcomes. However, cath lab staff, including interventional cardiologists, is consistently exposed to ionizing radiation, which poses inherent health risks. Radiation exposure in the cath lab primarily results from the use of fluoroscopy and cineangiography during diagnostic and interventional procedures. Understanding these risks and implementing effective radiation protection measurements are imperative to ensure the well-being of healthcare professionals while delivering high-quality cardiac care. Prolonged and repeated exposure can lead to both deterministic and stochastic effects. Deterministic effects, such as skin erythema and tissue damage, are more likely to occur at high radiation doses. Interventional cardiologists and staff may experience these effects when safety measures are not rigorously followed. In fact, while ionizing radiation is essential in the practice of radiation cardiology ward, cath lab staff faces inherent risks from radiation exposure. Stochastic effects, on the other hand, are characterized by a probabilistic relationship between radiation exposure and the likelihood of harm. These effects include the increased risk of cancer, particularly for those with long-term exposure. Interventional cardiologists, due to their frequent presence in the cath lab, face a higher lifetime cumulative radiation dose, potentially elevating their cancer risk. Protective measures, including the use of lead aprons, thyroid shields, and radiation monitoring devices, play a crucial role in reducing radiation exposure for cath lab personnel. Adherence to strict dose optimization protocols, such as minimizing fluoroscopy time and maximizing distance from the radiation source, is also essential in mitigating these risks. Ongoing research and advancements in radiation safety technology are essential in further for minimizing the adverse effects of ionizing radiation in the cath lab.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139680874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypofractionated Radiation Therapy Suppresses Radioresistance in U87 Human Glioma Cells by Inhibiting Yap1 and Hsp90 Proteins. 低分次放射治疗通过抑制 Yap1 和 Hsp90 蛋白抑制 U87 人胶质瘤细胞的放射抗性
IF 1.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-01 DOI: 10.2174/0118744710300495240409074900
Imran Khan, Sadaf Mahfooz, Busra Karacam, Elif Burce Elbasan, Kerime Akdur, Ganime Coban, Mustafa Aziz Hatiboglu

Background: Radiotherapy plays a vital role in the management of high-grade gliomas. However, the radio resistance of glioma cells limits the effect of radiation and drives recurrence inside the irradiated tumor volume leading to poor outcomes for patients.

Methods: High-grade glioma cell radioresistance significantly contributes to radiotherapy failure, highlighting the importance of identifying predictive biomarkers for radioresistance. An increasing body of evidence complies with the Yes Associated Protein 1 (Yap-1) and heat shock protein 90 (Hsp90) as biomarkers for radioresistance in glioma cells. A number of studies suggest the potential of radioresistance-associated factors as biomarkers and/ or novel therapeutic targets in glioma cells. Thus, it is essential for glioblastoma patients to identify robust druggable targets involved in radioresistance, optimizing irradiation protocol, and understanding their underlying molecular mechanisms.

Results: Therefore, in the present study, we hypothesized that hypofractionated Gamma Knife radiation therapy (HF-GKRT) could target Yap-1 and Hsp90 and downregulate the mechanism of radioresistance in high-grade glioma cells.

Conclusion: For this purpose, expression levels of radioresistance markers Yap-1 and Hsp90 were evaluated after treatment with HF-GKRT, and this was compared with single fraction Gamma Knife radiation therapy (SF-GKRT) in U87MG primary human glioblastoma cell line model. This would help design a novel radiation therapy regimen for glioblastoma patients by reducing the risk of radioresistance.

背景:放疗在治疗高级别胶质瘤中发挥着重要作用。方法:高级别胶质瘤细胞的放射抗性是放疗失败的重要原因,这凸显了确定放射抗性预测性生物标志物的重要性。越来越多的证据表明,是相关蛋白1(Yap-1)和热休克蛋白90(Hsp90)是胶质瘤细胞放射抗性的生物标志物。许多研究表明,放射抗性相关因子有可能成为胶质瘤细胞的生物标记物和/或新的治疗靶点。因此,对于胶质母细胞瘤患者来说,确定放射抗性相关的强效药物靶点、优化辐照方案并了解其潜在的分子机制至关重要:因此,在本研究中,我们假设低分次伽玛刀放射治疗(HF-GKRT)可以靶向Yap-1和Hsp90,并下调高级别胶质瘤细胞的放射抗性机制:为此,研究人员评估了高频-GKRT治疗后放射抗性标志物Yap-1和Hsp90的表达水平,并将其与U87MG原代人类胶质母细胞瘤细胞系模型中的单次分次伽玛刀放射治疗(SF-GKRT)进行了比较。这将有助于为胶质母细胞瘤患者设计新的放射治疗方案,降低放射抗性的风险。
{"title":"Hypofractionated Radiation Therapy Suppresses Radioresistance in U87 Human Glioma Cells by Inhibiting Yap1 and Hsp90 Proteins.","authors":"Imran Khan, Sadaf Mahfooz, Busra Karacam, Elif Burce Elbasan, Kerime Akdur, Ganime Coban, Mustafa Aziz Hatiboglu","doi":"10.2174/0118744710300495240409074900","DOIUrl":"10.2174/0118744710300495240409074900","url":null,"abstract":"<p><strong>Background: </strong>Radiotherapy plays a vital role in the management of high-grade gliomas. However, the radio resistance of glioma cells limits the effect of radiation and drives recurrence inside the irradiated tumor volume leading to poor outcomes for patients.</p><p><strong>Methods: </strong>High-grade glioma cell radioresistance significantly contributes to radiotherapy failure, highlighting the importance of identifying predictive biomarkers for radioresistance. An increasing body of evidence complies with the Yes Associated Protein 1 (Yap-1) and heat shock protein 90 (Hsp90) as biomarkers for radioresistance in glioma cells. A number of studies suggest the potential of radioresistance-associated factors as biomarkers and/ or novel therapeutic targets in glioma cells. Thus, it is essential for glioblastoma patients to identify robust druggable targets involved in radioresistance, optimizing irradiation protocol, and understanding their underlying molecular mechanisms.</p><p><strong>Results: </strong>Therefore, in the present study, we hypothesized that hypofractionated Gamma Knife radiation therapy (HF-GKRT) could target Yap-1 and Hsp90 and downregulate the mechanism of radioresistance in high-grade glioma cells.</p><p><strong>Conclusion: </strong>For this purpose, expression levels of radioresistance markers Yap-1 and Hsp90 were evaluated after treatment with HF-GKRT, and this was compared with single fraction Gamma Knife radiation therapy (SF-GKRT) in U87MG primary human glioblastoma cell line model. This would help design a novel radiation therapy regimen for glioblastoma patients by reducing the risk of radioresistance.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140854180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Validation of a Nomogram for Predicting Breast Malignancy in Male Patients Based on Clinical and Ultrasound Features. 基于临床和超声波特征预测男性患者乳腺恶性肿瘤的提名图的开发与验证
IF 1.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-01 DOI: 10.2174/0118744710274400231219060149
Wei-Hong Dong, Gang Wu, Nan Zhao, Juan Zhang

Objective: This study aimed to construct a nomogram based on clinical and ultrasound (US) features to predict breast malignancy in males.

Methods: The medical records between August, 2021 and February, 2023 were retrospectively collected from the database. Patients included in this study were randomly divided into training and validation sets in a 7:3 ratio. The models for predicting the risk of malignancy in male patients with breast lesions were virtualized by the nomograms.

Results: Among the 71 enrolled patients, 50 were grouped into the training set, while 21 were grouped into the validation set. After the multivariate analysis was done, pain, BI-RADS category, and elastography score were identified as the predictors for malignancy risk and were selected to generate the nomogram. The C-index was 0.931 for the model. Concordance between predictions and observations was detected by calibration curves and was found to be good in this study. The model achieved a net benefit across all threshold probabilities, which was shown by the decision curve analysis (DCA) curve.

Conclusion: We successfully constructed a nomogram to evaluate the risk of breast malignancy in males using clinical and US features, including pain, BI-RADS category, and elastography score, which yielded good predictive performance.

目的:本研究旨在根据临床和超声(US)特征构建一个预测男性乳腺恶性肿瘤的提名图:本研究旨在根据临床和超声波(US)特征构建预测男性乳腺恶性肿瘤的提名图:方法:从数据库中回顾性收集 2021 年 8 月至 2023 年 2 月期间的医疗记录。研究中的患者按 7:3 的比例随机分为训练集和验证集。通过提名图虚拟化了预测男性乳腺病变患者恶性肿瘤风险的模型:在 71 名登记的患者中,50 人被归入训练集,21 人被归入验证集。经过多变量分析,疼痛、BI-RADS 类别和弹性成像评分被确定为恶性肿瘤风险的预测因素,并被选中生成提名图。模型的 C 指数为 0.931。本研究通过校准曲线检测了预测值与观察值之间的一致性,结果显示两者之间的一致性良好。决策曲线分析(DCA)曲线显示,该模型在所有阈值概率上都取得了净收益:我们成功地构建了一个提名图,利用临床和超声特征(包括疼痛、BI-RADS 分类和弹性成像评分)来评估男性乳腺恶性肿瘤的风险,并取得了良好的预测效果。
{"title":"Development and Validation of a Nomogram for Predicting Breast Malignancy in Male Patients Based on Clinical and Ultrasound Features.","authors":"Wei-Hong Dong, Gang Wu, Nan Zhao, Juan Zhang","doi":"10.2174/0118744710274400231219060149","DOIUrl":"10.2174/0118744710274400231219060149","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to construct a nomogram based on clinical and ultrasound (US) features to predict breast malignancy in males.</p><p><strong>Methods: </strong>The medical records between August, 2021 and February, 2023 were retrospectively collected from the database. Patients included in this study were randomly divided into training and validation sets in a 7:3 ratio. The models for predicting the risk of malignancy in male patients with breast lesions were virtualized by the nomograms.</p><p><strong>Results: </strong>Among the 71 enrolled patients, 50 were grouped into the training set, while 21 were grouped into the validation set. After the multivariate analysis was done, pain, BI-RADS category, and elastography score were identified as the predictors for malignancy risk and were selected to generate the nomogram. The C-index was 0.931 for the model. Concordance between predictions and observations was detected by calibration curves and was found to be good in this study. The model achieved a net benefit across all threshold probabilities, which was shown by the decision curve analysis (DCA) curve.</p><p><strong>Conclusion: </strong>We successfully constructed a nomogram to evaluate the risk of breast malignancy in males using clinical and US features, including pain, BI-RADS category, and elastography score, which yielded good predictive performance.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139574642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Anti-hypoxia Potentials of Trans-sodium Crocetinate in Hypoxiarelated Diseases: A Review. 反式藏红花酸钠在低氧相关疾病中的抗缺氧电位研究进展
IF 2.3 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.2174/0118744710268127231020083505
Natalia S Klunko, Harun Achmad, Tamara Muayad Abdullah, Sami Mohammed, Indranil Saha, Khulood Saadoon Salim, Rasha Fadhel Obaid, Rosario Mireya Romero-Parra, Shaker Shanawa Al-Hasnawi, Wissam Hamid Al-Janabi, Bagher Farhood

Crocetin is a kind of apocarotenoid carboxylic acid extracted from saffron (Crocus sativus L.), which is effective in upregulating tissue oxygenation. However, crocetin is difficult to solubilize. It was shown that the trans isomer of crocetin is effective in improving oxygen diffusivity, while its cis isomer appears not to be. Hence, the isolated trans isomer of crocetin or trans-sodium crocetinate (TSC) can be used instead of crocetin. It is shown that TSC can upregulate hypoxic tissue oxygenation and be effective in treating some hypoxia-related diseases. Moreover, experimental and clinical studies have reported no adverse effects following TSC treatment, even at high doses. The current study will discuss the potential role of TSC in hemorrhagic shock, ischemia, brain tumor radiotherapy, and others.

番红花素是从藏红花(Crocus sativus L.)中提取的一种类胡萝卜素羧酸,可有效上调组织氧合。然而,番红花素很难溶解。结果表明,番红花素的反式异构体能有效提高氧扩散率,而其顺式异构体似乎不能。因此,可以用分离的番红花素反式异构物或番红花酸反式钠(TSC)代替番红花素。结果表明,TSC可以上调缺氧组织的氧合,对治疗某些缺氧相关疾病有效。此外,实验和临床研究报告称,即使在高剂量下,TSC治疗后也没有不良反应。目前的研究将讨论TSC在失血性休克、缺血、脑肿瘤放疗等方面的潜在作用。
{"title":"The Anti-hypoxia Potentials of Trans-sodium Crocetinate in Hypoxiarelated Diseases: A Review.","authors":"Natalia S Klunko, Harun Achmad, Tamara Muayad Abdullah, Sami Mohammed, Indranil Saha, Khulood Saadoon Salim, Rasha Fadhel Obaid, Rosario Mireya Romero-Parra, Shaker Shanawa Al-Hasnawi, Wissam Hamid Al-Janabi, Bagher Farhood","doi":"10.2174/0118744710268127231020083505","DOIUrl":"10.2174/0118744710268127231020083505","url":null,"abstract":"<p><p>Crocetin is a kind of apocarotenoid carboxylic acid extracted from saffron (<i>Crocus sativus</i> L.), which is effective in upregulating tissue oxygenation. However, crocetin is difficult to solubilize. It was shown that the trans isomer of crocetin is effective in improving oxygen diffusivity, while its cis isomer appears not to be. Hence, the isolated trans isomer of crocetin or trans-sodium crocetinate (TSC) can be used instead of crocetin. It is shown that TSC can upregulate hypoxic tissue oxygenation and be effective in treating some hypoxia-related diseases. Moreover, experimental and clinical studies have reported no adverse effects following TSC treatment, even at high doses. The current study will discuss the potential role of TSC in hemorrhagic shock, ischemia, brain tumor radiotherapy, and others.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50157196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy. 铁下垂诱导剂在癌症放射治疗中的应用前景。
IF 2.3 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.2174/0118744710262369231110065230
Fatemeh-Jalali Zefrei, Mohammd Shormij, Leila Dastranj, Maryam Alvandi, Zahra Shaghaghi, Soghra Farzipour, Nasim Zarei-Polgardani

Radiotherapy (RT) failure has historically been mostly attributed to radioresistance. Ferroptosis is a type of controlled cell death that depends on iron and is caused by polyunsaturated fatty acid peroxidative damage. Utilizing a ferroptosis inducer may be a successful tactic for preventing tumor growth and radiotherapy-induced cell death. A regulated form of cell death known as ferroptosis is caused by the peroxidation of phospholipids containing polyunsaturated fatty acids in an iron-dependent manner (PUFA-PLs). The ferroptosis pathway has a number of important regulators. By regulating the formation of PUFA-PLs, the important lipid metabolism enzyme ACSL4 promotes ferroptosis, whereas SLC7A11 and (glutathione peroxidase 4) GPX4 prevent ferroptosis. In addition to introducing the ferroptosis inducer chemicals that have recently been demonstrated to have a radiosensitizer effect, this review highlights the function and methods by which ferroptosis contributes to RT-induced cell death and tumor suppression in vitro and in vivo.

放射治疗(RT)失败历来主要归因于放射耐药。铁死亡是一种依赖于铁的受控细胞死亡,是由多不饱和脂肪酸过氧化损伤引起的。利用铁下垂诱导剂可能是一种成功的策略,以防止肿瘤生长和放疗诱导的细胞死亡。一种被称为铁凋亡的细胞死亡的调节形式是由含多不饱和脂肪酸的磷脂以铁依赖的方式过氧化引起的(PUFA-PLs)。铁下垂途径有许多重要的调节因子。通过调节PUFA-PLs的形成,重要的脂质代谢酶ACSL4促进铁下垂,而SLC7A11和(谷胱甘肽过氧化物酶4)GPX4则阻止铁下垂。除了介绍最近被证明具有放射增敏作用的铁下垂诱导剂化学物质外,本文还重点介绍了铁下垂在体外和体内促进rt诱导的细胞死亡和肿瘤抑制的功能和方法。
{"title":"Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy.","authors":"Fatemeh-Jalali Zefrei, Mohammd Shormij, Leila Dastranj, Maryam Alvandi, Zahra Shaghaghi, Soghra Farzipour, Nasim Zarei-Polgardani","doi":"10.2174/0118744710262369231110065230","DOIUrl":"10.2174/0118744710262369231110065230","url":null,"abstract":"<p><p>Radiotherapy (RT) failure has historically been mostly attributed to radioresistance. Ferroptosis is a type of controlled cell death that depends on iron and is caused by polyunsaturated fatty acid peroxidative damage. Utilizing a ferroptosis inducer may be a successful tactic for preventing tumor growth and radiotherapy-induced cell death. A regulated form of cell death known as ferroptosis is caused by the peroxidation of phospholipids containing polyunsaturated fatty acids in an iron-dependent manner (PUFA-PLs). The ferroptosis pathway has a number of important regulators. By regulating the formation of PUFA-PLs, the important lipid metabolism enzyme ACSL4 promotes ferroptosis, whereas SLC7A11 and (glutathione peroxidase 4) GPX4 prevent ferroptosis. In addition to introducing the ferroptosis inducer chemicals that have recently been demonstrated to have a radiosensitizer effect, this review highlights the function and methods by which ferroptosis contributes to RT-induced cell death and tumor suppression <i>in vitro</i> and <i>in vivo</i>.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136396776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Situ Photo Responsive Biodegradable Nanoparticle Forming Intrauterine Implant for Drug Delivery to Treat Ovarian Diseases: A Rationale-based Review. 原位光响应可生物降解纳米颗粒形成的子宫内植入物用于治疗卵巢疾病的药物递送:基于原理的综述。
IF 1.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-01 DOI: 10.2174/0118744710258313231105072931
Leander Corrie, Nagavendra Kommineni, Jaskiran Kaur, Ankit Awasthi, Raghunandan Gundaram, Latha Kukati

Ovarian disease constitutes various types of endocrine disorders, such as polycystic ovarian syndrome (PCOS), ovarian cancer, premature ovarian failure, ovarian endometriosis, and ovarian cysts. The prevalence of ovarian-related diseases is highly vulnerable in the world. The utility of various drug delivery systems for ovarian diseases has resulted in varied success. Moreover, most of them lead to severe adverse effects and are incapable of ameliorating the signs and symptoms of the condition. Intrauterine devices (IUDs) have positioned themselves as a mechanism to deliver the drug for various ovarian-related diseases. Thereby avoiding various stability-related issues arising due to various physiological barriers of the female reproductive tract. However, the use of intrauterine devices for drug delivery to the ovaries has not been fully explored. This is attributed to the fact that they cause cysts in the ovaries and skepticism among patients and physicians. Photo-sensitive devices are an appealing approach for managing disorders affecting the ovaries. Photo-sensitive in situ forming intrauterine implants (IUIs) have several advantages, including simplicity in application, reduced invasiveness, as well as improved site-specific drug release control. Polymeric nanoparticles (PNPs) loaded with a drug may be a suitable choice to provide sustained release, alter the pharmacokinetics, and reduce the dose and dosing frequency. The current manuscript hypothesizes the utility of a PNP-loaded biodegradable photo-responsive intrauterine implantable device as an alternate novel strategy for ameliorating ovarian-related diseases.

背景:卵巢疾病包括多囊卵巢综合征(PCOS)、卵巢癌、卵巢早衰、卵巢子宫内膜异位症和卵巢囊肿等多种内分泌疾病。卵巢相关疾病的患病率在世界上是非常脆弱的。卵巢疾病的各种药物输送系统的效用已导致不同的成功。此外,它们中的大多数会导致严重的不良反应,并且无法改善病情的体征和症状。假设:宫内节育器(iud)已经将自己定位为一种为各种卵巢相关疾病提供药物的机制。从而避免了由于女性生殖道的各种生理障碍而产生的各种与稳定性相关的问题。然而,使用宫内节育器将药物输送到卵巢尚未得到充分探索。这是因为它们会导致卵巢囊肿以及患者和医生的怀疑。光敏装置是一种有吸引力的方法来管理疾病影响卵巢。光敏原位形成宫内植入物(IUIs)有几个优点,包括应用简单,减少侵入性,以及改善部位特异性药物释放控制。聚合物纳米颗粒(PNPs)装载药物可能是提供缓释,改变药代动力学,减少剂量和给药频率的合适选择。结论:目前的论文假设pnp负载可生物降解的光反应宫内植入式装置作为改善卵巢相关疾病的替代新策略的实用性。
{"title":"<i>In Situ</i> Photo Responsive Biodegradable Nanoparticle Forming Intrauterine Implant for Drug Delivery to Treat Ovarian Diseases: A Rationale-based Review.","authors":"Leander Corrie, Nagavendra Kommineni, Jaskiran Kaur, Ankit Awasthi, Raghunandan Gundaram, Latha Kukati","doi":"10.2174/0118744710258313231105072931","DOIUrl":"10.2174/0118744710258313231105072931","url":null,"abstract":"<p><p>Ovarian disease constitutes various types of endocrine disorders, such as polycystic ovarian syndrome (PCOS), ovarian cancer, premature ovarian failure, ovarian endometriosis, and ovarian cysts. The prevalence of ovarian-related diseases is highly vulnerable in the world. The utility of various drug delivery systems for ovarian diseases has resulted in varied success. Moreover, most of them lead to severe adverse effects and are incapable of ameliorating the signs and symptoms of the condition. Intrauterine devices (IUDs) have positioned themselves as a mechanism to deliver the drug for various ovarian-related diseases. Thereby avoiding various stability-related issues arising due to various physiological barriers of the female reproductive tract. However, the use of intrauterine devices for drug delivery to the ovaries has not been fully explored. This is attributed to the fact that they cause cysts in the ovaries and skepticism among patients and physicians. Photo-sensitive devices are an appealing approach for managing disorders affecting the ovaries. Photo-sensitive <i>in situ</i> forming intrauterine implants (IUIs) have several advantages, including simplicity in application, reduced invasiveness, as well as improved site-specific drug release control. Polymeric nanoparticles (PNPs) loaded with a drug may be a suitable choice to provide sustained release, alter the pharmacokinetics, and reduce the dose and dosing frequency. The current manuscript hypothesizes the utility of a PNP-loaded biodegradable photo-responsive intrauterine implantable device as an alternate novel strategy for ameliorating ovarian-related diseases.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138458452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective Effects of Alpha-lipoic Acid, Resveratrol, and Apigenin Against Oxidative Damages, Histopathological Changes, and Mortality Induced by Lung Irradiation in Rats. α-硫辛酸、白藜芦醇和芹菜素对肺辐射诱导的大鼠氧化损伤、组织病理学变化和死亡率的保护作用。
IF 2.3 4区 医学 Q2 Medicine Pub Date : 2024-01-01 DOI: 10.2174/0118744710244357231018070313
Nasrin Seyedpour, Elahe Motevaseli, Shahram Taeb, Azin Nowrouzi, Fatemeh Mirzaei, Mina Bahri, Hamid Reza Dehghan-Manshadi, Mohsen Zhaleh, Khodabakhsh Rashidi, Rasool Azmoonfar, Rasoul Yahyapour, Masoud Najafi

Aim: This study investigated the protective effects of three antioxidants on radiationinduced lung injury.

Background: Oxidative stress is one of the key outcomes of radiotherapy in normal tissues. It can induce severe injuries in lung tissue, which may lead to pneumonitis and fibrosis. Recently, interest in natural chemicals as possible radioprotectors has increased due to their reduced toxicity, cheaper price, and other advantages.

Objective: The present study was undertaken to evaluate the radioprotective effect of Alpha-lipoic Acid (LA), Resveratrol (RVT), and Apigenin (APG) against histopathological changes and oxidative damage and survival induced by ionizing radiation (IR) in the lung tissues of rats.

Methods: First, the lung tissue of 50 mature male Wistar rats underwent an 18 Gy gamma irradiation. Next, the rats were sacrificed and transverse sections were obtained from the lung tissues and stained with hematoxylin and eosin (H and E) and Mason trichrome (MTC) for histopathological evaluation. Then, the activity of Glutathione peroxidase (GPx), Superoxide Dismutase (SOD), and Malondialdehyde (MDA) was measured by an ELISA reader at 340, 405, and 550 nm.

Results: Based on the results of this study, IR led to a remarkable increase in morphological changes in the lung. However, APG, RVT, and LA could ameliorate the deleterious effects of IR in lung tissue. IR causes an increase in GPX level, and APG+IR administration causes a decrease in the level of GPX compared to the control group. Also, the results of this study showed that RVT has significant effects in reducing MDA levels in the short term. In addition, compared to the control group, IR and RVT+IR decrease the activity of SOD in the long term in the lung tissues of rats. Also, the analysis of results showed that weight changes in IR, LA+IR, APG+IR, and control groups were statistically significant.

Conclusion: APG and RVT could prevent tissue damage induced by radiation effects in rat lung tissues. Hence, APG, LA, and RVT could provide a novel preventive action with their potential antioxidant anti-inflammatory properties, as well as their great safety characteristic.

目的:研究三种抗氧化剂对放射性肺损伤的保护作用。背景:氧化应激是正常组织放疗的主要结果之一。它会导致肺组织严重损伤,从而可能导致肺炎和纤维化。最近,由于天然化学品的毒性降低、价格低廉和其他优势,人们对其作为可能的放射性保护剂的兴趣增加了。目的:评价α-硫辛酸(LA)、白藜芦醇(RVT)和芹菜素(APG)对电离辐射(IR)引起的大鼠肺组织病理学变化、氧化损伤和存活的辐射保护作用。方法:首先对50只成年雄性Wistar大鼠肺组织进行18Gyγ射线照射。接下来,处死大鼠,从肺组织中获得横截面,并用苏木精和伊红(H和E)以及梅森三色染色(MTC)进行组织病理学评估。然后,通过ELISA读取器在340、405和550nm处测量谷胱甘肽过氧化物酶(GPx)、超氧化物歧化酶(SOD)和丙二醛(MDA)的活性。结果:根据本研究的结果,IR导致肺的形态学变化显著增加。然而,APG、RVT和LA可以改善IR对肺组织的有害影响。与对照组相比,IR导致GPX水平增加,并且APG+IR给药导致GPX的水平降低。此外,本研究的结果表明,RVT在短期内对降低MDA水平具有显著作用。此外,与对照组相比,IR和RVT+IR可长期降低大鼠肺组织SOD活性。此外,结果分析显示,IR、LA+IR、APG+IR和对照组的体重变化具有统计学意义。结论:APG和RVT可预防辐射对大鼠肺组织的损伤。因此,APG、LA和RVT可以提供一种新的预防作用,因为它们具有潜在的抗氧化、抗炎特性以及良好的安全性。
{"title":"Protective Effects of Alpha-lipoic Acid, Resveratrol, and Apigenin Against Oxidative Damages, Histopathological Changes, and Mortality Induced by Lung Irradiation in Rats.","authors":"Nasrin Seyedpour, Elahe Motevaseli, Shahram Taeb, Azin Nowrouzi, Fatemeh Mirzaei, Mina Bahri, Hamid Reza Dehghan-Manshadi, Mohsen Zhaleh, Khodabakhsh Rashidi, Rasool Azmoonfar, Rasoul Yahyapour, Masoud Najafi","doi":"10.2174/0118744710244357231018070313","DOIUrl":"10.2174/0118744710244357231018070313","url":null,"abstract":"<p><strong>Aim: </strong>This study investigated the protective effects of three antioxidants on radiationinduced lung injury.</p><p><strong>Background: </strong>Oxidative stress is one of the key outcomes of radiotherapy in normal tissues. It can induce severe injuries in lung tissue, which may lead to pneumonitis and fibrosis. Recently, interest in natural chemicals as possible radioprotectors has increased due to their reduced toxicity, cheaper price, and other advantages.</p><p><strong>Objective: </strong>The present study was undertaken to evaluate the radioprotective effect of Alpha-lipoic Acid (LA), Resveratrol (RVT), and Apigenin (APG) against histopathological changes and oxidative damage and survival induced by ionizing radiation (IR) in the lung tissues of rats.</p><p><strong>Methods: </strong>First, the lung tissue of 50 mature male Wistar rats underwent an 18 Gy gamma irradiation. Next, the rats were sacrificed and transverse sections were obtained from the lung tissues and stained with hematoxylin and eosin (H and E) and Mason trichrome (MTC) for histopathological evaluation. Then, the activity of Glutathione peroxidase (GPx), Superoxide Dismutase (SOD), and Malondialdehyde (MDA) was measured by an ELISA reader at 340, 405, and 550 nm.</p><p><strong>Results: </strong>Based on the results of this study, IR led to a remarkable increase in morphological changes in the lung. However, APG, RVT, and LA could ameliorate the deleterious effects of IR in lung tissue. IR causes an increase in GPX level, and APG+IR administration causes a decrease in the level of GPX compared to the control group. Also, the results of this study showed that RVT has significant effects in reducing MDA levels in the short term. In addition, compared to the control group, IR and RVT+IR decrease the activity of SOD in the long term in the lung tissues of rats. Also, the analysis of results showed that weight changes in IR, LA+IR, APG+IR, and control groups were statistically significant.</p><p><strong>Conclusion: </strong>APG and RVT could prevent tissue damage induced by radiation effects in rat lung tissues. Hence, APG, LA, and RVT could provide a novel preventive action with their potential antioxidant anti-inflammatory properties, as well as their great safety characteristic.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":2.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71421606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Advancement and Future Prospects: Biomedical Nanoengineering. 生物医学纳米工程的现状与展望。
IF 1.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-01-01 DOI: 10.2174/0118744710274376231123063135
Sonia Singh, Hrishika Sahani

Recent advancements in biomedicine have seen a significant reliance on nanoengineering, as traditional methods often fall short in harnessing the unique attributes of biomaterials. Nanoengineering has emerged as a valuable approach to enhance and enrich the performance and functionalities of biomaterials, driving research and development in the field. This review emphasizes the most prevalent biomaterials used in biomedicine, including polymers, nanocomposites, and metallic materials, and explores the pivotal role of nanoengineering in developing biomedical treatments and processes. Particularly, the review highlights research focused on gaining an in-depth understanding of material properties and effectively enhancing material performance through molecular dynamics simulations, all from a nanoengineering perspective.

由于传统方法在利用生物材料的独特属性方面常常达不到要求,生物医学最近的进展已经看到了对纳米工程的重大依赖。纳米工程已经成为增强和丰富生物材料性能和功能的一种有价值的方法,推动了该领域的研究和发展。本文着重介绍了高分子材料、纳米复合材料和金属材料等生物医学领域应用最为广泛的生物材料,并探讨了纳米工程在生物医学治疗和工艺发展中的关键作用。特别是,本文重点介绍了从纳米工程的角度出发,通过分子动力学模拟深入了解材料特性并有效提高材料性能的研究。
{"title":"Current Advancement and Future Prospects: Biomedical Nanoengineering.","authors":"Sonia Singh, Hrishika Sahani","doi":"10.2174/0118744710274376231123063135","DOIUrl":"10.2174/0118744710274376231123063135","url":null,"abstract":"<p><p>Recent advancements in biomedicine have seen a significant reliance on nanoengineering, as traditional methods often fall short in harnessing the unique attributes of biomaterials. Nanoengineering has emerged as a valuable approach to enhance and enrich the performance and functionalities of biomaterials, driving research and development in the field. This review emphasizes the most prevalent biomaterials used in biomedicine, including polymers, nanocomposites, and metallic materials, and explores the pivotal role of nanoengineering in developing biomedical treatments and processes. Particularly, the review highlights research focused on gaining an in-depth understanding of material properties and effectively enhancing material performance through molecular dynamics simulations, all from a nanoengineering perspective.</p>","PeriodicalId":10991,"journal":{"name":"Current radiopharmaceuticals","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138498055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current radiopharmaceuticals
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1